The Manila Times3h
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates
AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical ...
Measles prevention: How the two-dose regimen works
About 90% of the U.S. population has gotten their two-dose regimen to protect against measles, mumps and rubella, but ...
American Chemical Society18h
Improving GLP-1 drug delivery by ‘painting’ it on antibodies
Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss., ...